Dialysis Catheter Market Size, Share, & Trends Analysis | Global | 2026-2032 | Includes: Hemodialysis and Peritoneal Dialysis Catheters

Global Dialysis Catheter Market Report to 2032

The global dialysis catheter market was valued at $331 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 2.6%, reaching over $397 million by 2032.

This report covers the global market for dialysis catheters, including long-term hemodialysis catheters, short-term hemodialysis catheters, and peritoneal dialysis catheters.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by initiatives to reduce infection, the increasing number of dialysis patients, and the adoption of advanced catheter materials and antimicrobial technologies. However, catheter infection rates and the increasing use of AV fistulae continue to limit stronger growth.

Market Overview

The global dialysis catheter market includes catheters used to provide vascular or peritoneal access for patients requiring dialysis. These devices are essential for patients who require immediate access, temporary access, or long-term dialysis support when other access methods are not suitable.

The market includes long-term hemodialysis catheters, short-term hemodialysis catheters, and peritoneal dialysis catheters. Long-term hemodialysis catheters are generally used when catheter retention is expected to exceed three weeks, with dwell times that can extend for months or years.

Short-term hemodialysis catheters are used when access is not expected to exceed three weeks or when emergency dialysis access is needed. These devices are important in acute care settings where rapid placement is required.

Technological advancements are shaping the dialysis catheter landscape by improving safety and performance. Innovation is focused on better biocompatibility, reduced infection risk, improved durability, antimicrobial coatings, and enhanced materials. These features help justify higher ASPs and support market value growth.

Market Drivers

Initiatives to Reduce Infection

Initiatives to reduce catheter-related bloodstream infections are a major driver of the dialysis catheter market. Infection reduction efforts have been supported by organizations such as the Institute for Healthcare Improvement, the Centers for Disease Control and Prevention, and Medicare reimbursement policy changes.

Medical facilities have responded positively because infections are preventable expenses that worsen patient outcomes. Reducing catheter-related infection is now a major priority for hospitals, dialysis centers, and healthcare systems.

This focus is expected to increase demand for catheters with infection-reducing properties. Antimicrobial catheters also sell at a premium, which supports market value growth even when unit growth remains moderate.

Increasing Number of Dialysis Patients

The increasing number of dialysis patients is another important market driver. End-stage renal disease is a chronic condition that can be treated through dialysis, and dialysis catheters remain necessary for many patients.

Growth in the dialysis patient population is driven by several factors, including aging populations, rising hypertension rates, and increasing rates of obesity and diabetes.

After accounting for kidney transplants and mortality, there is a net annual increase of around 4% in the number of prevalent dialysis patients. Many dialysis patients also use more than one catheter per year, resulting in even faster catheter volume growth. This trend is expected to remain steady over the forecast period.

Advanced Materials and Catheter Design

Advanced materials and catheter design improvements are supporting market growth. Given the historic challenge of catheter-related infections and complications, manufacturers are developing catheters with improved biocompatibility, durability, and safety features.

Premium technologies include antimicrobial coatings, heparin coatings, silver sleeves, kink-resistant shafts, tissue ingrowth cuffs, and specialized catheter tip designs. These features are intended to reduce infection, improve patency, limit thrombosis, and improve clinical performance.

Because these technologies can command higher prices, they support ASP growth and market value. Advanced material catheters are expected to remain an important area of innovation in both acute and long-term dialysis care.

Market Limiters

Infection Rates

Infection rates remain one of the main limiters of the dialysis catheter market. Dialysis catheters have higher infection rates than arteriovenous fistulae or AV grafts.

Because of this, dialysis catheters are often used as a last resort when fistulae or grafts are not suitable or not yet available. Catheter-related infections can lead to poor outcomes, higher costs, and additional treatment needs.

Many dialysis patients have co-existing medical conditions and are not suitable for fistulae or grafts, which preserves catheter demand. However, a meaningful increase in the percentage of patients using dialysis catheters is unlikely unless infection and complication rates decline.

Increasing Use of AV Fistulae

The increasing use of AV fistulae is another limiter. While greater use of AV fistulae has not had a drastic impact on the catheter market as of 2022, this may change over time.

As physicians become better at anticipating future dialysis needs, they may prepare fistulae in advance. This can reduce the need for dialysis catheters, especially in patients who can transition directly to fistula access.

AV fistulae are generally preferred because they have lower infection rates and better long-term access profiles than catheters. As planning improves, some catheter demand may be eliminated.

Competition from Alternative Access Methods

Dialysis catheters also face competition from alternative access methods, including AV grafts and peritoneal dialysis approaches, depending on patient condition and care pathway.

When patients are suitable for fistulae or grafts, these options may be preferred over long-term catheter use because of lower infection and complication risks.

This limits catheter growth in long-term care. Dialysis catheters remain essential for urgent access, bridge access, and patients who are not suitable for alternatives, but their role is constrained by efforts to reduce catheter dependence where possible.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
• Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, and forecast assumptions.
• Device scope: The report covers dialysis catheters, including long-term hemodialysis catheters, short-term hemodialysis catheters, and peritoneal dialysis catheters. Long-term hemodialysis catheters are further divided into conventional and advanced material catheters.

Markets Covered and Segmentation

Dialysis Catheter Market

• Device type: Hemodialysis and peritoneal dialysis.

Hemodialysis catheters include both long-term and short-term devices. Long-term hemodialysis catheters are used when catheter retention is expected to exceed three weeks and may remain in place for months or years. This segment includes conventional and advanced material catheters.

Short-term hemodialysis catheters are used when access is needed for less than three weeks or when emergency dialysis access is required. These products are important in acute and urgent care settings where rapid access is necessary.

Peritoneal dialysis catheters are used to support peritoneal dialysis, allowing dialysis fluid to be introduced and drained through the peritoneal cavity. These devices serve a different access pathway than hemodialysis catheters and are included within the broader dialysis catheter market.

Each segment is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

This segmentation helps manufacturers, investors, and strategy teams understand how acute access, chronic access, infection prevention, advanced materials, and dialysis patient growth are shaping the global dialysis catheter market.

Competitive Analysis

Becton Dickinson held a strong position in the total dialysis catheter market in 2025, particularly in long-term and short-term hemodialysis catheters. Although the company does not offer a peritoneal dialysis catheter, BD's aggressive marketing strategy and volume discounts have helped it gain share.

BD dominates the market for power-injectable short-term hemodialysis catheters with devices such as Power-Trialysis(R) and DuoGlide(R), which provide high flow rates with low recirculation and thermosensitive polyurethane shafts. Its long-term hemodialysis catheter portfolio includes Equistream(R), Duet(R), HemoSplit(R), HemoStar(R), GlidePath(R), Decathlon(TM) DF, Reliance XK(TM), and Pristine(TM).

Medtronic held the second-leading position in the total dialysis catheter market in 2025. The company performed strongly in short-term hemodialysis and dominated the peritoneal dialysis segment through its Argyle(TM) peritoneal dialysis catheter line, including Tenckhoff, Curl Cath, Swan Neck, Missouri, and Presternal designs.

Medtronic also participates in long-term hemodialysis through Mahurkar(TM) chronic Carbothane and silicone catheters, Permcath(TM), Tandem-Cath(TM), and Palindrome(TM). In January 2023, Medtronic issued a Class I recall of its Mahurkar(TM) Acute Dual Lumen High Flow 13.5 Fr catheters due to potential catheter hub defects.

Medcomp held the third-leading position in the total dialysis catheter market in 2025. The company is especially strong in long-term dialysis catheters and maintains a stable presence in short-term dialysis and peritoneal dialysis catheters. Its Split Stream(R) and Split Cath(R) products helped establish its presence, while the Trio-CT power-injectable short-term catheter supports growth.

Technology and Practice Trends

Antimicrobial Catheter Adoption

Antimicrobial catheters are becoming more important as hospitals and dialysis centers focus on reducing catheter-related bloodstream infections.

These products command premium pricing and support market value growth.

Advanced Material Catheters

Advanced material catheters are designed to improve biocompatibility, durability, and resistance to complications.

These features help address infection, thrombosis, patency, and catheter performance concerns.

Power-Injectable Hemodialysis Catheters

Power-injectable short-term hemodialysis catheters are gaining importance in acute care settings. These devices support high flow rates and can offer additional clinical flexibility.

BD's Power-Trialysis(R) and DuoGlide(R) products are examples of this trend.

Long-Term Catheter Design Improvements

Long-term hemodialysis catheter designs are improving through features such as tissue ingrowth cuffs, kink-resistant shafts, specialized tip designs, and antimicrobial coatings.

These improvements are intended to support longer dwell times and fewer complications.

Peritoneal Dialysis Access

Peritoneal dialysis catheters remain an important part of the market. Medtronic's Argyle(TM) line supports a broad range of peritoneal dialysis access needs.

This segment serves patients using peritoneal rather than hemodialysis treatment pathways.

AV Fistula Planning

Improved planning for AV fistula creation may reduce future catheter demand. As clinicians anticipate dialysis needs earlier, some patients may avoid catheter use or use catheters for shorter durations.

This trend may constrain long-term catheter growth.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global dialysis catheter market today, and how much is it expected to grow through 2032?
• How are long-term hemodialysis, short-term hemodialysis, and peritoneal dialysis catheter segments performing?
• How are unit sales, procedure numbers, ASPs, and market values changing over time?
• How is the increasing number of dialysis patients affecting catheter demand?
• What role do antimicrobial coatings and advanced materials play in market value growth?
• Why are catheter-related bloodstream infections a major focus for hospitals and dialysis centers?
• How do AV fistulae and AV grafts limit dialysis catheter use?
• How are power-injectable hemodialysis catheters changing acute access options?
• Which companies lead the global dialysis catheter market?
• How are BD, Medtronic, and Medcomp positioned across long-term hemodialysis, short-term hemodialysis, and peritoneal dialysis catheter segments?

The Global Dialysis Catheter Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand infection-reduction trends, and support commercial planning in the global dialysis catheter market.